NMR spectroscopy and cancer research: the present and the future.

[1]  O. Klepp,et al.  Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. , 1990, The New England journal of medicine.

[2]  P. Okunieff,et al.  Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. , 1990, The New England journal of medicine.

[3]  R. Shulman.  NMR--another cancer-test disappointment. , 1990, The New England journal of medicine.

[4]  W. Mackinnon,et al.  Uterine cervical punch biopsy specimens can be analyzed by 1h mrs , 1990, Magnetic resonance in medicine.

[5]  J. Glickson,et al.  Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia. , 1989, Biochimica et biophysica acta.

[6]  Truman R. Brown,et al.  In vivo1 values of phosphorus metabolites in human liver and muscle determined at 1.5T by chemical shift imaging , 1989 .

[7]  C. Mountford,et al.  Elevated apolipoprotein(A) levels in cancer patients , 1989, International journal of cancer.

[8]  H. Issaq,et al.  An NMR blood test for cancer: a critical assessment , 1988, NMR in biomedicine.

[9]  P. Wilding,et al.  Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy. , 1988, Clinical chemistry.

[10]  M. Tattersall,et al.  PROTEOLIPID IDENTIFIED BY MAGNETIC RESONANCE SPECTROSCOPY IN PLASMA OF A PATIENT WITH BORDERLINE OVARIAN TUMOUR , 1987, The Lancet.

[11]  J. M. Carr,et al.  Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. , 1986, The New England journal of medicine.

[12]  M. Tattersall,et al.  CLASSIFICATION OF HUMAN TUMOURS BY HIGH-RESOLUTION MAGNETIC RESONANCE SPECTROSCOPY , 1986, The Lancet.

[13]  W. Mackinnon,et al.  NMR methods for characterizing the state of the surfaces of complex mammalian cells. , 1984, Journal of biochemical and biophysical methods.